MARKET

GDTC

GDTC

CytoMed Therapeutics Ltd
NASDAQ
1.770
-0.080
-4.32%
After Hours: 1.770 0 0.00% 16:10 12/05 EST
OPEN
1.710
PREV CLOSE
1.850
HIGH
1.800
LOW
1.710
VOLUME
11.63K
TURNOVER
--
52 WEEK HIGH
4.050
52 WEEK LOW
1.650
MARKET CAP
20.77M
P/E (TTM)
-7.0772
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GDTC last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at GDTC last week (1117-1121)?
Weekly Report · 11/24 10:02
CytoMed completes acquisition of T cell technology of TC BioPharm
TipRanks · 11/18 14:37
CytoMed Therapeutics Finalizes Acquisition of T Cell Technology for Cancer Treatment in China and India
TipRanks · 11/18 13:27
Weekly Report: what happened at GDTC last week (1110-1114)?
Weekly Report · 11/17 10:02
Weekly Report: what happened at GDTC last week (1103-1107)?
Weekly Report · 11/10 10:00
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 11/06 17:05
Cytomed Therapeutics secures investment for subsidiary LongevityBank
TipRanks · 11/06 13:42
More
About GDTC
CytoMed Therapeutics Limited is a biopharmaceutical company. It is focused on harnessing its licensed proprietary technologies, namely gamma delta T cell and gamma delta Natural Killer T cel to create cell-based immunotherapies for the treatment of human cancers. The development of its technologies has been inspired by the clinical success of existing CAR-T in treating hematological malignancies as well as the clinical limitations and commercial challenges in extrapolating the CAR-T principle into treatment of solid tumors. Its product candidates include CTM-N2D, iPSC-gdNKT, and CTM-GDT. CTM-N2D is a lead product candidate that consists of expanded gamma delta T cells grafted with NKG2DL-targeting CAR to enhance anti-cancer cytotoxicity. The iPSC-gdNKT product candidate utilizes iPSC as a starting material to generate gdNKT, which is a synthetic hybrid of a gamma delta T cell and a NK cell. The Company also has the allogeneic gamma delta T cell technology, namely TCB-002.

Webull offers CytoMed Therapeutics Ltd stock information, including NASDAQ: GDTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GDTC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GDTC stock methods without spending real money on the virtual paper trading platform.